(Total Views: 442)
Posted On: 02/06/2020 6:13:04 AM
Post# of 145254
I’m not sure why 350mg and not 700mg?
“The basket trial is a Phase 2 study with 30 patients with CCR5+ locally advanced or metastatic solid tumors. Leronlimab will be administered subcutaneously as a weekly dose of 350 mg.”
“The basket trial is a Phase 2 study with 30 patients with CCR5+ locally advanced or metastatic solid tumors. Leronlimab will be administered subcutaneously as a weekly dose of 350 mg.”
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)